IPGP enters today's Q1 print on the back foot, having surrendered most of its post-February gains in a punishing week, and the question is whether the underlying business can justify even the reduced valuation.
The price action sets a cautious backdrop. The stock closed Monday at $116.67 — down 6.3% on the day and off 7.3% on the week — retracing sharply after peaking above $137 in late February following a blowout Q4. That prior-quarter beat was emphatic: the stock jumped nearly 39% on the day and held most of the move into the following week. The bar heading into today's release is considerably less forgiving, with the stock having already given back meaningful ground without a fresh catalyst. Options positioning remains skewed bullish rather than defensive — the put/call ratio is just 0.21, well below its 20-day average of 0.18 and only mildly above it on a z-score basis. That is a low reading relative to the 52-week range of 0.06–0.53, suggesting options traders are not rushing for downside cover.
Short sellers have not rushed in either, though momentum flipped sharply on Friday. Short Interest as a percentage of free float is a modest 4.6%, but shares short jumped 13.5% in a single session on April 24 — the largest one-day move in the trailing 30 days. Utilization has actually eased over the month, dropping from the low-20s to 17.1%, well short of the 52-week high of 27.3%. Borrowing costs remain negligible at 0.53%. The signal is mixed: not a heavily loaded short position, but late-week re-engagement from bears on a day when the stock was already sliding.
The bull and bear cases are in genuine tension. Bulls point to a track record of beating estimates — IPGP ranks in the 81st percentile on EPS surprise and the 83rd on 90-day EPS momentum — and to structural diversification away from its China-heavy industrial laser base. Analysts who revised sharply upward after Q4, with Stifel lifting its target from $92 to $165 and Raymond James moving to $180, still hold constructive ratings. Bears focus on slowing industrial capex, tariff headwinds, and the risk that the Q4 surge reflected a one-time demand flush rather than a durable inflection. EV/EBITDA has compressed to roughly 22x on today's levels, down meaningfully from the post-Q4 peak, but with forward EPS growth ranked only in the 31st percentile, the multiple still requires execution. Note that the most recent analyst target revisions date from mid-February and may not fully reflect subsequent macro deterioration.
Ownership adds one notable wrinkle. The Valentin Gapontsev Trust and IP Fibre Devices — the two largest holders with a combined 31% of shares — both trimmed in the last reported period, as did the CEO, CFO, and most of the senior leadership team on February 27, all selling at prices near $131. Those sales came immediately after the Q4 pop. The earnings report will test whether the operational momentum that triggered that insider confidence — at much lower pre-Q4 prices — has carried through into the new fiscal year.
See the live data behind this article on ORTEX.
Open IPGP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
